Table of Contents

Particulars Page
Executive Summary I-II
Part 1.0. Introduction of the Report………………………………...... 1-4

1.1. Background of the report 1

1.2. Significance of the report 1
 1.3. Scope of the report 2
 1.4. Objectives of the report 2
 1.5. Methodology 3
 1.6. Limitations 4
Part 2.0. Overview of the Company………………………………....... 5-20
 2.1. Background 5
 2.2. Vision 8
 2.3. Mission 8
 2.4. Objective 8
 2.5. Corporate Focus 8
 2.6. Organogram 9
 2.7. Management System and Style 10
 2.8. Financial Highlights of SPL 19
Part 3.0. Theoretical Background……………………………………... 21-28
 3.1. Ratio Analysis 21
 3.1.1. Importance of Ratio Analysis 21
 3.1.2. Types of Ratio Comparisons 22
 3.1.3. Cautions about Ratio Analysis 22
 3.1.4. Group of Financial Ratios 23
 3.2. Trend Analysis 28
Part 4.0. Analysis & Findings ……………………………………......... 29-53

4.1 World Pharmaceuticals Industry Review 29

4.2. Bangladesh Pharmaceuticals Industry Overview 30

4.3. About Square Pharmaceuticals Ltd. 31

4.4. Qualitative Analysis (SWOT analysis) of SPL 33

4.6. Quantitative Analysis of SPL 34
4.6.1. Ratio Analysis of SPL 34
4.6.2. Trend Analysis of SPL 52
Part 5.0. Comparative Analysis of SPL with BPL & ACI Ltd………… 54-85
 5.1. About Beximco Pharmaceuticals Ltd. 54
 5.2. Qualitative Analysis (SWOT analysis) of BPL 55
 5.3. About Advanced Chemical Industries Ltd. 56
 5.4. Qualitative Analysis (SWOT analysis) of ACI 57
 5.5. Comparative Quantitative Analysis 58
5.5.1. Comparative Ratio Analysis 58
5.5.2. Comparative Trend Analysis 76
Part 6.0. Major Findings…………………………………………………. 86-92
 6.1. Findings on SPL 86
 6.2. Comparative Findings on SPL, BPL & ACI Ltd. 88
Part 7.0. Recommendations……………………………………………… 93
Part 8.0. Conclusion………………………………………………………. 94
Part 9.0. Bibliography……………………………………………………. 95
Part 10.0. Annexure………………………………………………………… ---